Preliminary Scientific Programme

08.30 – 10.15

Main Symposium - History of Allergy, Past to Future

Room: Hall D

Chairpersons:
Kristof Nekam, Hungary
Brunello Wüthrich, Switzerland

The beginning
Karl-Christian Bergmann, Germany

Development of allergology in Europe
Brunello Wüthrich, Switzerland

Allergology in the USA
Robert Esch, United States

The future of allergology as a discipline
Gabrielle Pauli, France

Main Symposium - Urticaria

Room: Hall E2

Chairpersons:
Clive Grattan, United Kingdom
Torsten Zuberbier, Germany

Mast cells in health and disease
Peter Valent, Austria

Epidemiology and triggers
Torsten Zuberbier, Germany

Common and rare clinical pictures of urticaria
Clive Grattan, United Kingdom

Modern aspects of treatment
Carsten Bindslev-Jensen, Denmark

Main Symposium - Allergy, Asthma and Sports

Room: Hall G

Chairpersons:
Kai-Håkon Carlsen, Norway
Stefano Del Giacco, Italy

Sports and immune system: what's new?
Stefano Del Giacco, Italy

Nutrition, exercise and immune function - facts and fiction
Andre Moreira, Portugal

Exercise-induced urticaria/anaphylaxis: diagnostic workup
Antonino Romano, Italy

How to treat your allergic athlete ... legally!
Kai-Håkon Carlsen, Norway

Main Symposium - The Clinical Impact of Functional Genomics and     Proteomics

Room: Hall B

Chairperson:
Mikael Benson, Sweden
Tim Myers, United States

Genome-wide association studies
Young-Ae Lee, Germany

Protein microarrays for allergy research
Reinhard Hiller, South Africa

Successful strategies for microarray studies in allergy research
Tim Myers, United States

Clinical implications
Mikael Benson, Sweden

Oral Abstract Session - Diagnostic Methods in Occupational Asthma

Room: Hall H

Chairpersons:
Piero Maestrelli, Italy
Monika Raulf-Heimsoth, Germany

Introductory lecture: Laboratory tests in diagnosing occupational asthma
Piero Maestrelli, Italy

10.30 – 12.15

Main Symposium - Control of Inflammation in Asthma

Room: Hall I/K

Chairpersons:
Judah Denburg, Canada
Jan Lötvall, Sweden

The link between the bone marrow and asthma
Judah Denburg, Canada

Sputum monitoring and the prevention of asthma exacerbations
Chris Brighting, United Kingdom

Tissue haemopoiesis: effects of therapy
Jan Lötvall, Sweden

How aggressively should one treat the underlying inflammation in asthma
Peter Sterk, The Netherlands

Main Symposium - Infections and Allergy

Room: Hall E2

Chairpersons:
Thomas Platts-Mills, United States
Isil Barlan, Turkey

Susceptibility to infection in asthma
Thomas Platts-Mills, United States

Role of atypical bacteria and macrolides in asthma
Nikolaos Papadopoulos, Greece

Mycobacteria and allergy
Isil Barlan, Turkey

The role of infections and life style in the development of atopy (the KOALA Birth Cohort Study)
Carel Thijs, The Netherlands

Main Symposium - Novel Strategies for Prevention of Atopy

Room: Hall D

Chairpersons:
Bengt Björkstén, Sweden
Patrick Holt, Australia

Novel immunomodulatory strategies for the prevention of atopy and asthma
Eckard Hamelmann, Germany

Role of functional foods
Bengt Björkstén, Sweden

Novel approaches in immunotherapy
Rudolf Valenta, Austria

Clinical perspectives of early exposure to allergens
Patrick Holt, Australia

PRACTALL Symposium - “Diagnosis and treatment of atopic dermatitis – the EAACI/AAAI PRACTALL consensus”

Chairpersons:
Anthony Frew, United Kingdom
Lanny Rosenwasser, United States

The natural history of atopic dermatitis and its determinants
Lanny Rosenwasser, United States

Diagnostic approach in the clinical
Carsten Bindslev-Jensen, Denmark

Topical and systemic treatment
Alexander Kapp, Germany

Oral Abstract Session: Late breaking reports in basic allergology

Chairperson:
Dieter Maurer, Austria

Oral Abstract Session: Late breaking reports in clinical allergology

Chairperson:
Bodo Niggemann, Germany

13.15 - 15.00

Plenary Session 4 - New Horizons in Diagnosis and Treatment

Room: Hall F

Chairperson:
Ronald van Ree, The Netherlands
Rudolf Valenta, Austria

Development of recombinant allergens
Heimo Breiteneder, Austria

Recombinant allergens in basic and clinical allergy research
Stefan Vieths, Germany

Recombinant allergens for diagnosis
Ronald van Ree, The Netherlands

Recombinant allergens for therapy and prevention
Marianne van Hage, Sweden

15.15 - 16.15

Closing Ceremony/Summary/Prizes

Room: Hall F

Summary on molecular allergology
Fatima Ferreira, Austria

Summary on cellular allergology
Cezmi Akdis, Switzerland

Summary on clinical allergology
Anthony Frew, United Kingdom

All delegates attending the Closing Ceremony will be eligible to participate in a
lottery where the prize is a weekend for two in Vienna. To participate in the lottery, delegates will have to answer a few questions regarding the plenary lectures. The lucky winners will be among those who have answered the questions correctly and who will be present at the Closing Ceremony.

[To the top]